BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36441170)

  • 1. MiRNA-139-3p inhibits malignant progression in urothelial carcinoma of the bladder via targeting KIF18B and inactivating Wnt/beta-catenin pathway.
    Zhang W; Liu Z
    Pharmacogenet Genomics; 2023 Jan; 33(1):1-9. PubMed ID: 36441170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of miRNA-93-5p Promotes Proliferation and Migration of Bladder Urothelial Carcinoma via Inhibition of KLF9.
    Li T; Xu Q; Wei Y; Lin R; Hong Z; Zeng R; Hu W; Wu X
    Comput Math Methods Med; 2022; 2022():8911343. PubMed ID: 35495878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIF18B promotes hepatocellular carcinoma progression through activating Wnt/β-catenin-signaling pathway.
    Yang B; Wang S; Xie H; Wang C; Gao X; Rong Y; Liu Z; Lu Y
    J Cell Physiol; 2020 Oct; 235(10):6507-6514. PubMed ID: 32052444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-582-3p targeting ribonucleotide reductase regulatory subunit M2 inhibits the tumorigenesis of hepatocellular carcinoma by regulating the Wnt/β-catenin signaling pathway.
    Xu H; Li B
    Bioengineered; 2022 May; 13(5):12876-12887. PubMed ID: 35609318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiRNA-301b-3p induces proliferation and inhibits apoptosis in AML cells by targeting FOXF2 and regulating Wnt/β-catenin axis.
    Lu Y; Zhong L; Luo X; Liu C; Dan W; Chu X; Wan P; Zhang Z; Wang X; Liu Z; Liu B
    Mol Cell Probes; 2022 Jun; 63():101805. PubMed ID: 35259424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIF18B promotes breast cancer cell proliferation, migration and invasion by targeting TRIP13 and activating the Wnt/β-catenin signaling pathway.
    Liu L; Zhang Z; Xia X; Lei J
    Oncol Lett; 2022 Apr; 23(4):112. PubMed ID: 35251343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-522-3p plays an oncogenic role in glioblastoma through activating Wnt/β-catenin signaling pathway via targeting SFRP2.
    Zhang L; Zhang P; Tan Y; Feng Q; Zhao R
    Neuroreport; 2021 Jan; 32(2):88-98. PubMed ID: 33395185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-139-3p/Kinesin family member 18B axis suppresses malignant progression of gastric cancer.
    Ke H; Wu S; Zhang Y; Zhang G
    Bioengineered; 2022 Feb; 13(2):4528-4536. PubMed ID: 35137670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PXDNL activates the motility of urothelial bladder carcinoma cells through the Wnt/β-catenin pathway and has a prognostic value.
    Lu M; Liu B; Li D; Gao Z; Li W; Zhou X; Zhan H
    Life Sci; 2023 Jan; 312():121270. PubMed ID: 36493879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircTET1 Inhibits Retinoblastoma Progression via Targeting miR-492 and miR-494-3p through Wnt/β-catenin Signaling Pathway.
    Fu C; Wang S; Jin L; Zhang M; Li M
    Curr Eye Res; 2021 Jul; 46(7):978-987. PubMed ID: 33108919
    [No Abstract]   [Full Text] [Related]  

  • 11. miR-29a-3p promotes migration and invasion in ameloblastoma via Wnt/β-catenin signaling by targeting catenin beta interacting protein 1.
    Liu S; Liu D; Liu J; Liu J; Zhong M
    Head Neck; 2021 Dec; 43(12):3911-3921. PubMed ID: 34636093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
    Xiong L; Tang Y; Tang J; Liu Z; Wang X
    Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
    [No Abstract]   [Full Text] [Related]  

  • 13. MicroRNA miR-331-3p suppresses osteosarcoma progression via the Bcl-2/Bax and Wnt/β-Catenin signaling pathways and the epithelial-mesenchymal transition by targeting N-acetylglucosaminyltransferase I (MGAT1).
    Bi W; Yang M; Xing P; Huang T
    Bioengineered; 2022 Jun; 13(6):14159-14174. PubMed ID: 35758024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-144-3p inhibits cell proliferation of colorectal cancer cells by targeting BCL6 via inhibition of Wnt/β-catenin signaling.
    Sun N; Zhang L; Zhang C; Yuan Y
    Cell Mol Biol Lett; 2020; 25():19. PubMed ID: 32206063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling.
    Guan B; Ma J; Yang Z; Yu F; Yao J
    Environ Toxicol; 2021 Aug; 36(8):1640-1653. PubMed ID: 33974352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.
    Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B
    World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of NRARP exerts anti-tumor activities in the breast tumor cells depending on Wnt/β-catenin-mediated signals: The role of miR-130a-3p.
    Poodineh J; Sirati-Sabet M; Rajabibazl M; Ghasemian M; Mohammadi-Yeganeh S
    Chem Biol Drug Des; 2022 Sep; 100(3):334-345. PubMed ID: 35797350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The osteogenic differentiation of human adipose-derived stem cells is regulated through the let-7i-3p/LEF1/β-catenin axis under cyclic strain.
    Luo Y; Ge R; Wu H; Ding X; Song H; Ji H; Li M; Ma Y; Li S; Wang C; Du H
    Stem Cell Res Ther; 2019 Nov; 10(1):339. PubMed ID: 31753039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-409-3p promotes osteoblastic differentiation via activation of Wnt/β-catenin signaling pathway by targeting SCAI.
    Chen N; Yang H; Song L; Li H; Liu Y; Wu D
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33274736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYPT1, regulated by miR-19b-3p inhibits the progression of non-small cell lung cancer via inhibiting the activation of wnt/β-catenin signaling.
    Wang Y; Wang L; Guo J; Zuo S; Wang Z; Hua S
    Life Sci; 2021 Aug; 278():119573. PubMed ID: 33964297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.